Friday, Sep 30, 2022



Delighted to receive approval for Covovax children in 7+ age group: Adar Poonawalla

June 30, 2022 3:57 am

The DCGI had granted permission for conducting phase 3 clinical trial of Covovax as a booster dose in adults who had been fully vaccinated with either Covaxin or Covishield.

Only 500 shots of SII's Covovax administered in Delhi in two months

June 27, 2022 10:47 am

Around 80 per cent of the children in the age group of 12 to 14 years and more between the ages of 15 and 17 years have received the first dose of their vaccine.

Few takers for Covovax, say two Delhi hospitals administering vaccine

May 30, 2022 6:50 pm

There are 160 slots available daily for Covovax shots together in Makkar and Virmani hospitals, according to CoWIN. Each dose of the protein subunit vaccine will cost Rs 386 (including charges of the hospital and GST).

Private hospitals in Delhi start administering Covovax shots, priced at Rs 386

May 30, 2022 12:08 pm

Covovax is the second Covid-19 vaccine manufactured by the SII along with the most commonly used Covishield.

NTAGI panel recommends inclusion of Covovax in vaccination drive for 12-17 age group

April 30, 2022 7:56 am

India's drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 last year and in the 12-17 age group, subject to certain conditions, on March 9.

Thailand gets 2 lakh doses of India-made Covovax

April 22, 2022 1:00 am

The doses were handed over to Thai Deputy Prime Minister Anutin Charnvirakul in Bangkok by Indian Ambassador Suchitra Durai, Australian envoy Allan McKinnon, Japan’s Nashida Kazuya and US Charge d’Affaires James Wayman.

Drug regulator grants emergency use authorisation to Covovax for 12-17 age group

March 09, 2022 8:05 pm

It is the fourth vaccine to receive the regulator's nod for use among those below 18 years.

SII seeks permission for phase-3 study of Covid vaccine Covovax as booster dose in adults

February 27, 2022 7:20 pm

The Drugs Controller General Of India (DCGI) had approved Covovax for restricted use in emergency situations in adults on December 28. The vaccine is yet to be included in the country's inoculation programme.

PGI recruits 32 kids aged 2 to 6 years for Covovax vaccine trials

February 26, 2022 5:01 am

The vaccine will be produced by the Pune-based Serum Institute of India and PGI is among the 10 institutes across the country contributing to completing the recruitments under the vaccine trial.

Serum Institute seeks EUA for its Covovax vaccine for 12-17 yrs age group

February 21, 2022 7:55 pm

The Drugs Controller General Of India has already approved Covovax for restricted use in emergency situations in adults on December 28.